Advancing Global Research Partnerships

Drawing on the success of two previously held international scientific summits, the George Washington University (GW) Office of International Medicine Programs (IMP) and the GW School of Medicine and Health Sciences (SMHS) organized a third summit in December 2017, this time convening GW researchers with colleagues in Madrid to focus on increasing research collaborations between the United States and Spain and developing the global physician-scientist workforce.

The summit was developed by the GW Cancer Center, SMHS researchers, and IMP, alongside Spanish co-sponsors Puerta de Hierro Hospital and Research Institute and the Universidad Autonoma de Madrid.

Researchers and leaders at the summit

Eduardo M. Sotomayor, MD, director of the GW Cancer Center, director of the Division of Hematology/Oncology at the GW Medical Faculty Associates, and professor of medicine at SMHS, said one goal of the summit was to find common areas of biomedical interest between the institutions that could lead to strong collaborations. At the end of the summit, areas that emerged for partnership consideration included liquid biopsies in lung cancer and other solid malignancies, biology and immunotherapy of lymphomas, and skin malignancies.

Latest News

The George Washington University (GW) Medical Faculty Associates (MFA) is extending its reach in suburban communities, expanding primary care services and bringing convenient, high-quality, and comprehensive health care to Northern Virginia, suburban Maryland, and the Washington, D.C., metropolitan…
Medicine is slowly evolving into a multimedia arena, one that melds in-person visits with technology-based care. This shift has been convenient and cost-effective for both patients and doctors, but it also has opened an avenue to care for a specific patient population: the elderly.
The George Washington University School of Medicine and Health Sciences, under the leadership of Maranda C. Ward, EdD ’17, has been awarded a pair of grants totaling more than $816,000 from Gilead Sciences Inc., in support of an 18-month research-informed educational initiative, Two in One: HIV+…